Imed Inc is categorized under Medical Insurance Claim Processing, Contract or Fee Basis in Frisco, TX and active since 1999.
Imed Inc was established in 1999, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Insurance Claim Processing, Contract or Fee Basis business, which does work in the B2B market, and is classified as a Medical Insurance Claim Processing, Contract or Fee Basis, under code number 524292 by the NAICS.
If you are seeking more information, feel free to contact Charles Brawner at the company’s single location by writing to 11625 Custer Road # 110343, Frisco, Texas TX 75035 or by phoning (972) 381-9282. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Imed Inc |
Contact Person: | Charles Brawner |
Address: | 11625 Custer Road # 110343, Frisco, Texas 75035 |
Phone Number: | (972) 381-9282 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Insurance Claim Processing, Contract or Fee Basis |
SIC Code: | 6411 |
NAICS Code: | 524292 |
Share This Business: |
Imed Inc was started in 1999 to provide professional Medical Insurance Claim Processing, Contract or Fee Basis under the SIC code 6411 and NAICS code 524292. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Charles Brawner for inquiries that concern Imed Inc by calling the company number (972) 381-9282, as your correspondence is most welcome. Additionally, the physical location of the single location of Imed Inc can be found at the coordinates 33.172015,-96.733074 as well as the street address 11625 Custer Road # 110343 in Frisco, Texas 75035.
For its online presence, you may visit Imed Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.